{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:36:35Z","timestamp":1760888195378},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1053\/j.seminoncol.2007.10.002","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T03:11:54Z","timestamp":1208229114000},"page":"S28-S32","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S4","title":["Management of Bisphosphonate Treatment in Clinical Practice"],"prefix":"10.1053","volume":"34","author":[{"given":"Matti S.","family":"Aapro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.seminoncol.2007.10.002_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: Clinical experience","volume":"9","author":"Coleman","year":"2004","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: Long term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jnci\/93.7.534","article-title":"Methodology for treatment evaluation in patients with cancer metastatic to bone","volume":"93","author":"Cook","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib6","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1053\/j.seminoncol.2007.10.002_bib7","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1097\/01.JTO.0000283345.76753.da","article-title":"Bone metastases from non-small cell lung cancer (NSCLC) result in meaningful skeletal morbidity within a patient\u2019s lifetime","volume":"2","author":"Hirsh","year":"2007","journal-title":"J Thor Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib8","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib9","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib10","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","article-title":"Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients\u2014May 2006","volume":"62","author":"Weitzman","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.breast.2007.02.007","article-title":"Patients\u2019 knowledge and experience of adjuvant endocrine therapy for early breast cancer: A European study","volume":"16","author":"Wengstrom","year":"2007","journal-title":"Breast"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/annonc\/mdj044","article-title":"Patients\u2019 preference for administration of endocrine treatments by injection or tablets: Results from a study of women with breast cancer","volume":"17","author":"Fallowfield","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib14","first-page":"341","article-title":"Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice","volume":"4","author":"Delea","year":"2006","journal-title":"J Support Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib15","first-page":"533","article-title":"Impact of skeletal complications on total medical care costs in lung cancer patients with bone metastases","volume":"22","author":"Delea","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib16","first-page":"531","article-title":"Impact of skeletal complications on total medical care costs in prostate cancer patients with bone metastases","volume":"22","author":"McKiernan","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdl093","article-title":"Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases","volume":"17","author":"Botteman","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2007.10.002_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.9-90004-28","article-title":"Safety of intravenous and oral bisphosphonates and compliance with dosing regimens","volume":"9","author":"Conte","year":"2004","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib19","series-title":"Adherence to bisphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk","author":"Silverman","year":"2005"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib21","doi-asserted-by":"crossref","first-page":"698s","DOI":"10.1200\/jco.2006.24.18_suppl.18623","article-title":"Higher persistency with i.v. bisphosphonates in patients with bone metastasis","volume":"24","author":"Mangiapane","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/annonc\/mdi122","article-title":"The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer","volume":"16","author":"Weinfurt","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib23","first-page":"260","article-title":"Determinants of reduced survival following hip fractures in men","volume":"319","author":"Poor","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib25","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1053\/j.seminoncol.2007.10.002_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"suppl","key":"10.1053\/j.seminoncol.2007.10.002_bib27","first-page":"S26","article-title":"Early phase in the development of a bone metastases quality of life module","volume":"19","author":"Chow","year":"2007","journal-title":"Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T09:07:56Z","timestamp":1588583276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775407002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":27,"alternative-id":["S0093775407002047"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2007.10.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}